Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Wii Balance Board in Dizziness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01345422
Recruitment Status : Withdrawn (The study never started since it did not receive IRB approval)
First Posted : May 2, 2011
Last Update Posted : December 9, 2015
Sponsor:
Information provided by (Responsible Party):
Kaiser Permanente

Brief Summary:
Patients with dizziness presently undergo physical therapy rehabilitation. Our study will study whether Wii Balance Board made by Nintendo Inc. will be helpful in patients with dizziness. They will undergo dizziness evaluation to quantify their dizziness.

Condition or disease Intervention/treatment Phase
Dizziness Other: Wii Balance Board Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: A Pilot Study to Assess the Usefulness of the Wii Balance Board for Dizziness

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Wii Balance Board
Wii Balance Board Training
Other: Wii Balance Board
Participant will undergo Nintendo Wii Balance Board training for two months , five days a week for 30 minutes





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Abnormal posturography exam

Exclusion Criteria:

  • Pregnant Women and children

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01345422


Sponsors and Collaborators
Kaiser Permanente
Investigators
Layout table for investigator information
Principal Investigator: David Cheng, MD Southern California Permanente Medical Group
Layout table for additonal information
Responsible Party: Kaiser Permanente
ClinicalTrials.gov Identifier: NCT01345422    
Other Study ID Numbers: HNS1
First Posted: May 2, 2011    Key Record Dates
Last Update Posted: December 9, 2015
Last Verified: December 2015
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: this study did not receive IRB approval
Additional relevant MeSH terms:
Layout table for MeSH terms
Vertigo
Dizziness
Sensation Disorders
Neurologic Manifestations
Signs and Symptoms
Vestibular Diseases
Labyrinth Diseases
Ear Diseases
Otorhinolaryngologic Diseases
Nervous System Diseases